Search results
From Self-sufficiency
- ...ver-the-counter]] (OTC) quinine as a treatment for nocturnal leg cramps. [[Pfizer]] [[Pharmaceuticals]] had been selling the brand name Legatrin for this pur27 KB (3,844 words) - 15:41, 27 September 2010
- ...he [[United Kingdom|UK]] and [[Israel]], by [[Parke-Davis]], now part of [[Pfizer]]. In the USSR and post-USSR countries, it was/is marketed as '''Дифен12 KB (1,686 words) - 15:42, 27 September 2010
- ...ates)|U.S. Food and Drug Administration]] (FDA) approval in 1967, becoming Pfizer's first once-a-day broad-spectrum antibiotic. Other brand names include Mon20 KB (2,578 words) - 15:43, 27 September 2010
- ...Infectiouslogy]. Accessed Mar. 22, 2010 9:00am.</ref> It is marketed by [[Pfizer]] under the trade name '''Flagyl''' in the US, by [[Sanofi-Aventis]] global .../download/uspi_flagyl_375.pdf ''Flagyl 375 U.S. Prescribing Information''] Pfizer (PDF)</ref> It appears to have a fairly low potential for cancer risk and19 KB (2,528 words) - 15:43, 27 September 2010
- ...s commonly marketed under the trade name '''Diflucan''' or '''Trican''' ([[Pfizer]]). In Mexico it is sold over the counter as '''Alfumet'''. It is marketed ...0}} It is interesting to note that, when fluconazole was in development at Pfizer, it was decided early in the process to avoid producing any [[Chirality (ch11 KB (1,533 words) - 15:44, 27 September 2010
- ...cologia. (2009): 223-7.</ref><ref>Pfizer. Amphocin. Accessed at http://www.pfizer.com/files/products/uspi_amphocin.pdf on Feb 18 2010.</ref>13 KB (1,785 words) - 15:44, 27 September 2010
- ...euticals was acquired by Warner Lambert in 1999 and is now a subsidiary of Pfizer. It is marketed in Europe by [[Hoffman-La Roche]]. [[Category:Pfizer]]8 KB (1,160 words) - 15:45, 27 September 2010
- ...nd [[veterinary medicine]] developed by [[Parke-Davis]] (today a part of [[Pfizer]]) in 1962. Its [[hydrochloride]] [[salt (chemistry)|salt]] is sold as '''K Ketanest S Parke Davis (Pfizer) - S enantiomer only, no preservatives<ref name="PMID15055891">{{Cite journ69 KB (9,697 words) - 20:01, 24 September 2010
- ...ket in Central and Eastern Europe under the brand name of Sumamed in 1988, Pfizer Zithromax in 1991, and Zentiva Azitrox. After several years, the [[Food and ...e and the numerals 3060 on the other. Greenstone, Ltd. is a subsidiary of Pfizer. The Novartis subsidiary Sandoz ships azithromycin as white oval tablets st15 KB (2,008 words) - 15:46, 27 September 2010
- * '''Convulex''' ([[Pfizer]] in the UK and Byk Madaus in South Africa)25 KB (3,328 words) - 15:47, 27 September 2010
- ...|date=September 2007}}</ref> '''Clavamox''' (for [[veterinary]] use by [[Pfizer]]).7 KB (895 words) - 15:48, 27 September 2010
- |author=[[Pfizer]] |publisher=[http://www.pfizer.com/home/ Pfizer Inc.]12 KB (1,641 words) - 14:32, 16 September 2010
- *Xalacom (Pfizer) - timolol and latanoprost4 KB (476 words) - 15:46, 19 September 2010
- ...L.H. Conover, Abraham Bavley, Richard Pasternack, and Peter P. Regna) at [[Pfizer]] [http://www.jstor.org/stable/3931295] [http://pqasb.pqarchiver.com/djrepr11 KB (1,417 words) - 20:55, 19 September 2010
- ...l 2001 advancing to pre-clinical stage. Based on the piperidine structure, Pfizer pursued the task of designing ketopiperazine-based renin inhibitors which h5 KB (697 words) - 08:44, 20 September 2010
- ...d for dogs in the United States, and distributed in the United States by [[Pfizer]] Animal Health and by [[Novartis]] Animal Health in Canada under the produ ...effects can be reversed using [[atipamezole]] (distributed as Antisedan by Pfizer). IV use of atipamezole is not licensed, IM is the preferred route. [[Yohi6 KB (885 words) - 12:14, 20 September 2010
- ...''[[Aspergillus niger]]'' could be efficient citric acid producers, and [[Pfizer]] began industrial-level production using this technique two years later, f20 KB (2,855 words) - 19:16, 21 September 2010
- * [[Pfizer]] – [[Charles Pfizer]]43 KB (4,797 words) - 20:06, 21 September 2010
- ...is the brand name of a range of [[migraine]]-relief medications made by [[Pfizer]]. ..., KT20 7NS <ref>{{cite web | title=Pfizer official website| url=http://www.pfizer.com}}</ref>2 KB (271 words) - 21:05, 21 September 2010
- On April 7, 2005, Pfizer withdrew Bextra from the U.S. market on recommendation by the FDA, citing a Pfizer first acknowledged cardiovascular risks associated with Bextra in October 26 KB (784 words) - 21:05, 21 September 2010